Page last updated: 2024-10-22

aminoglutethimide and Uterine Diseases

aminoglutethimide has been researched along with Uterine Diseases in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Uterine Diseases: Pathological processes involving any part of the UTERUS.

Research Excerpts

ExcerptRelevanceReference
" Additionally, compound 2 inhibited androstenedione-induced uterine hypertrophy in sexually immature mice (41% of uterine weight suppression for compound 2 versus 51% for AG)."3.71Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone. ( Blanco, JG; Bocco, JL; Flury, A; Genti-Raimondi, S; Gil, RR; Meragelman, TL, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanco, JG1
Gil, RR1
Bocco, JL1
Meragelman, TL1
Genti-Raimondi, S1
Flury, A1

Other Studies

1 other study available for aminoglutethimide and Uterine Diseases

ArticleYear
Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors;

2001